Storing and Travelling Details

How do I store and travel with HUMIRA?

Keep HUMIRA in the outer carton until it is time to use it. HUMIRA must be kept in the refrigerator (2- 8°C) but don’t allow it to freeze. If you are travelling, a single HUMIRA pre-filled pen or pre-filled syringe may be stored at room temperature (below 25°C) for a maximum period of 14 days, but it must be protected from light. Once removed from the refrigerator for room temperature storage, the syringe or pen must be used within 14 days or discarded even if it is returned to the refrigerator. If additional syringes or pens are being carried, they should be refrigerated (kept between 2-8°C).

When planning to travel overseas it is important that you:

talk to your doctor about travelling with HUMIRA
carry a letter from your doctor detailing what HUMIRA is, how much you will be taking, and stating that it is for your own personal use
leave HUMIRA in its original packaging so it is clearly labelled with your name and dosage instructions (if you are taking HUMIRA pens/syringes with you)
You should carry your HUMIRA with you as hand luggage onto the airplane. Confirm with the airline about carrying HUMIRA on the plane and through customs
keep HUMIRA at the correct storage conditions outlined above

This site is intended for a New Zealand audience.

Important information about HUMIRA. HUMIRA is a prescription medicine containing adalimumab. HUMIRA is available as a single use pre-filled syringe or single-use pre-filled pen and may contain 20mg, 40mg or 80mg adalimumab. It is used in the treatment of patients with rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, enthesitis-related arthritis, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis, psoriasis, ulcerative colitis, Crohn’s disease, non-infectious uveitis, and hidradenitis suppurativa. HUMIRA is only used in patients of a specific age group, in diseases of certain severity (e.g. moderate to severe), and/or after some other treatments have been tried (e.g. conventional therapy).

HUMIRA has risks and benefits. Refer to the Safety Information contained on this website for further details. If you have any questions about using HUMIRA, ask your healthcare professional and refer to the Consumer Medicine Information (CMI) available here: HUMIRA PEN CMI or HUMIRA Pre-filled Syringe CMI or by calling freephone 0800 900 030. Ask your doctor if HUMIRA is right for you. Use strictly as directed. If symptoms continue, or you have side effects, see your doctor, pharmacist or healthcare professional.

HUMIRA is a funded prescription medicine under special authorial criteria – for certain indications and patients only. Your doctor can inform you if you are eligible to receive funding. Normal pharmacy and doctor's charge will apply.

AbbVie is the company that brings you HUMIRA (adalimumab). For more information about AbbVie, visit www.AbbVie.co.nz | HUMIRA Data Sheet

AbbVie Limited, 6th floor, 156-158 Victoria street, Wellington, 6011, New Zealand. Ph: 0800 900 030. HUMIRA and Destination You are registered trademarks of AbbVie Biotechnology Ltd.